J. H. E. Dambrink

584 total citations
24 papers, 376 citations indexed

About

J. H. E. Dambrink is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J. H. E. Dambrink has authored 24 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J. H. E. Dambrink's work include Acute Myocardial Infarction Research (17 papers), Coronary Interventions and Diagnostics (6 papers) and Cardiac Imaging and Diagnostics (6 papers). J. H. E. Dambrink is often cited by papers focused on Acute Myocardial Infarction Research (17 papers), Coronary Interventions and Diagnostics (6 papers) and Cardiac Imaging and Diagnostics (6 papers). J. H. E. Dambrink collaborates with scholars based in Netherlands, United States and Italy. J. H. E. Dambrink's co-authors include Arnoud W.J. van ‘t Hof, Jan Paul Ottervanger, Jan C.A. Hoorntje, Harry Suryapranata, A.T. Marcel Gosselink, Menko Jan de Boer, Angela H.E.M. Maas, A. Otten, Elvin Kedhi and M. J. de Boer and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and American Heart Journal.

In The Last Decade

J. H. E. Dambrink

24 papers receiving 365 citations

Peers

Countries citing papers authored by J. H. E. Dambrink

Since Specialization

Citations

This map shows the geographic impact of J. H. E. Dambrink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. H. E. Dambrink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. H. E. Dambrink more than expected).

Fields of papers citing papers by J. H. E. Dambrink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. H. E. Dambrink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. H. E. Dambrink. The network helps show where J. H. E. Dambrink may publish in the future.

Co-authorship network of co-authors of J. H. E. Dambrink

This figure shows the co-authorship network connecting the top 25 collaborators of J. H. E. Dambrink. A scholar is included among the top collaborators of J. H. E. Dambrink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. H. E. Dambrink. J. H. E. Dambrink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: Insight from the On-TIME II trial 2020 ·American Heart Journal ·Enrico Fabris, Jurriën M. ten Berg, Renicus S. Hermanides, Jan Paul Ottervanger, J. H. E. Dambrink, (unknown), Gianfranco Sinagra, Petra C. Koopmans, Evangelos Giannitsis, Christian W. Hamm, Arnoud W.J. van ‘t Hof	7
2	Influence of coronary calcification on hyperemic response during fractional flow reserve measurements 2019 ·International Journal of Cardiology ·(unknown), Jan Paul Ottervanger, Mohamed Mouden, J. H. E. Dambrink, Jorik R. Timmer, Piet L. Jager	2
3	One-year clinical outcome of early administration of intravenous beta-blockers in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary reperfusion 2018 ·EuroIntervention ·Vincent Roolvink, Jan Paul Ottervanger, Borja Ibáñez, J. H. E. Dambrink, M. Gosselink, Elvin Kedhi, Niels van Royen, Erik Lipšic, Wouter Remkes, Jan J. Piek, Valentı́n Fuster, Arnoud W.J. van ‘t Hof	5
4	Use, timing and outcome of coronary angiography in patients with high-risk non-ST-segment elevation acute coronary syndrome in daily clinical practice: insights from a ‘real world’ prospective registry 2018 ·Netherlands Heart Journal ·Erik Badings, Rik Hermanides, Aize van der Sluis, J. H. E. Dambrink, A.T. Marcel Gosselink, Elvin Kedhi, Jan Paul Ottervanger, Vincent Roolvink, Wouter Remkes, (unknown), Harry Suryapranata, Arnoud W.J. van ‘t Hof	8
5	Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry 2018 ·European Heart Journal - Cardiovascular Pharmacotherapy ·(unknown), Peter Damman, Jan Paul Ottervanger, J. H. E. Dambrink, A.T. Marcel Gosselink, Elvin Kedhi, Evelien Kolkman, Robbert J. de Winter, Arnoud W.J. van ‘t Hof	20
6	Cardiogenic Shock Predicts Long‐term Mortality in Hospital Survivors of STEMI Treated With Primary Percutaneous Coronary Intervention 2016 ·Clinical Cardiology ·(unknown), Jan Paul Ottervanger, Arnoud W.J. van ‘t Hof, J. H. E. Dambrink, M. Gosselink, Elvin Kedhi, Harry Suryapranata, (unknown)	13
7	Effects of radial versus femoral artery access in patients with acute myocardial infarction: A large centre prospective registry 2016 ·Netherlands Heart Journal ·(unknown), (unknown), Renicus S. Hermanides, Jan Paul Ottervanger, Evelien Kolkman, J. H. E. Dambrink, Vincent Roolvink, A.T. Marcel Gosselink, Elvin Kedhi, Arnoud W.J. van ‘t Hof	7
8	The extent of ST elevation and ST deviation as predictors of mortality in ST-segment elevation myocardial patients planned to undergo primary percutaneous coronary intervention 2015 ·International Journal of Cardiology ·Sonja Postma, J. H. E. Dambrink, A.T. Marcel Gosselink, Jan Paul Ottervanger, Evelien Kolkman, Jurriën M. ten Berg, Harry Suryapranata, Arnoud W.J. van ‘t Hof	4
9	The influence of residential distance on time to treatment in ST-elevation myocardial infarction patients 2014 ·Netherlands Heart Journal ·Sonja Postma, J. H. E. Dambrink, M. J. de Boer, A.T. Marcel Gosselink, Jan Paul Ottervanger, Petra C. Koopmans, Jurriën M. ten Berg, Harry Suryapranata, Arnoud W.J. van ‘t Hof	15
10	A comparison of 2 second generation drug eluting stents (Zotarolimus versus Everolimus), in elective PCI patients 2013 ·European Heart Journal ·Wouter Remkes, Samer Somi, Vincent Roolvink, J. P. Ottervanger, A.T. Marcel Gosselink, Jan C.A. Hoorntje, J. H. E. Dambrink, M. J. de Boer, Harry Suryapranata, Arnoud W.J. van ‘t Hof	1
11	Atrial fibrillation after but not before primary angioplasty for ST-segment elevation myocardial infarction of prognostic importance 2012 ·Netherlands Heart Journal ·(unknown), Rypko Beukema, Arif Elvan, Jan Paul Ottervanger, M. J. de Boer, Jan C.A. Hoorntje, Harry Suryapranata, J. H. E. Dambrink, A.T. Marcel Gosselink, Arnoud W.J. van ‘t Hof	18
12	Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial 2010 ·EuroIntervention ·Jorik R. Timmer, Jurriën M. ten Berg, Antonius A.C.M. Heestermans, Thorsten Dill, (unknown), J. H. E. Dambrink, Harry Suryapranata, Jan Paul Ottervanger, Christian W. Hamm, Arnoud W.J. van ‘t Hof	11
13	Therapeutic mild hypothermia improves outcome after out-of-hospital cardiac arrest 2009 ·Netherlands Heart Journal ·(unknown), (unknown), (unknown), (unknown), (unknown), J. H. E. Dambrink, Arnoud W.J. van ‘t Hof	19
14	Routine upstream versus selective down stream use of tirofiban in non-ST elevation myocardial infarction patients scheduled for early invasive therapy; a randomized comparison 2007 ·Journal of Thrombosis and Thrombolysis ·Saman Rasoul, Jan Paul Ottervanger, Menko Jan de Boer, J. H. E. Dambrink, Harry Suryapranata, Jan C.A. Hoorntje, A.T. Marcel Gosselink, Arnoud W.J. van ‘t Hof, (unknown)	3
15	Electrical storms in Brugada syndrome successfully treated with isoproterenol infusion and quinidine orally 2007 ·Netherlands Heart Journal ·(unknown), (unknown), Anand R. Ramdat Misier, Willem P. Beukema, (unknown), Henk Oude Luttikhuis, J. H. E. Dambrink, Jan C.A. Hoorntje, Arif Elvan	37
16	Circumflex artery-related acute myocardial infarction: limited ECG abnormalities but poor outcome 2007 ·Netherlands Heart Journal ·Saman Rasoul, M. J. de Boer, (unknown), Jan C.A. Hoorntje, A.T. Marcel Gosselink, Felix Zijlstra, J. P. Ottervanger, J. H. E. Dambrink, Arnoud W.J. van ‘t Hof	32
17	Platelet microaggregation inhibition in patients with acute myocardial infarction pretreated with tirofiban and relationship with angiographic and clinical outcome 2006 ·American Heart Journal ·Jaap Jan J. Smit, Nicolette Ernst, Robbert J. Slingerland, Jeroen J. Kolkman, Harry Suryapranata, Jan C.A. Hoorntje, J. H. E. Dambrink, Jan Paul Ottervanger, A.T. Marcel Gosselink, Menko Jan de Boer, Arnoud W.J. van ‘t Hof	5
18	Successful reperfusion for acute ST elevation myocardial infarction is associated with a decrease in WBC count 2006 ·Journal of Laboratory and Clinical Medicine ·Jaap Jan J. Smit, Jan Paul Ottervanger, Robbert J. Slingerland, Harry Suryapranata, Jan C.A. Hoorntje, J. H. E. Dambrink, A.T. Marcel Gosselink, Menko‐Jan de Boer, Arnoud W.J. van ‘t Hof	8
19	Dysglycemia in suspected acute coronary syndromes 2005 ·European Journal of Internal Medicine ·Jorik R. Timmer, (unknown), Jan Paul Ottervanger, J. H. E. Dambrink, Kor Miedema, (unknown), Felix Zijlstra	7
20	No mortality benefit of primary angioplasty over thrombolytic therapy in patients with nonanterior myocardial infarction at long-term follow-up: Results of the zwolle trial 2003 ·Journal of the American College of Cardiology ·(unknown), José P.S. Henriques, (unknown), J. H. E. Dambrink, M. Gosselink, (unknown), Menko Jan de Boer, Felix Zijlstra	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact